Mallinckrodt Securities Litigation
April 15, 2025. Parties in the Mallinckrodt securities matter (District of New Jersey) agreed to settle for $46 million. Plaintiff alleged that Mallinckrodt had made materially false and misleading statements about the Company’s failure to pay the full rebates owed to the Centers for Medicare and Medicaid Services. Professor Steven Feinstein of Babson College and […]
VMware, Inc. Securities Litigation
March 31, 2025. The Court in the VMware, Inc. securities matter (Northern District of California) approved a class action settlement in the amount of $102.5 million. Plaintiff alleged that VMware had made materially false and misleading statements about an artificial sales backlog to hide slowing sales. Professor Steven Feinstein of Babson College and Crowninshield Financial […]
Envision Healthcare Securities Litigation
March 21, 2024. The Court in the Envision Healthcare Corporation securities matter (Middle District of Tennessee) approved a class action settlement in the amount of $177.5 million. Plaintiffs alleged that Envision artificially inflated its earnings through out-of-network billing, illegal upcoding, and inflated facility spending. Professor Steven Feinstein of Babson College and Crowninshield Financial Research provided […]
Aegean Marine Petroleum Network Securities Litigation
October 19, 2023. The Court in the Aegean Marine Petroleum Network securities matter (Southern District of New York) approved a $11.9 million settlement between Aegean shareholders and individual defendants. Previously, PWC Greece and Deloitte Greece agreed to pay $14.9 million each to settle with Aegean shareholders. Plaintiffs alleged that the individual defendants had taken part […]
Grupo Televisa Securities Litigation
April 20, 2023. The Parties agreed to and the Court approved a $95 million settlement in a class action lawsuit filed against Grupo Televisa. Plaintiffs alleged that Grupo Televisa paid bribes to Fédération Internationale de Football Association (“FIFA”) executives for World Cup broadcast rights. According to Plaintiffs, the concealed scheme artificially inflated the market price […]
Synchrony Financial Securities Litigation
April 12, 2023. The Parties agreed to and the Court approved a $34 million settlement in a class action securities case involving Synchrony Financial. Plaintiffs alleged that Synchrony misrepresented the quality of its loan portfolio and underwriting practices. Professor Steven Feinstein of Babson College and Crowninshield Financial Research provided expert analysis and testimony on market […]
Cardinal Health Securities Litigation
April 4, 2023. The Parties agreed to and the Court approved a $109 million settlement in a class action securities litigation brought against Cardinal Health. Plaintiffs alleged that Cardinal failed to disclose inventory and supply chain issues at Cordis Corp., an operating unit the company acquired. Professor Steven Feinstein of Babson College and Crowninshield Financial […]
Splunk Securities Litigation
February 27, 2023. The parties in the Splunk Inc. Securities Litigation (Northern District of California) agreed to a $30 million class action settlement. Plaintiffs alleged that Splunk had falsely claimed that the company was on track to produce $1 billion in operating cash flow by 2023. Poor quarterly financial results that allegedly revealed previously concealed […]
Inovio Pharmaceuticals Securities Litigation
January 18, 2023. The Parties agreed to and the Court approved a $44 million settlement in a class action lawsuit filed against Inovio Pharmaceuticals. Plaintiffs alleged that the Company made misleading statements about its ability to quickly produce an effective Covid-19 vaccine. According to Plaintiffs, the misrepresentation inflated the Company’s stock price and caused investor […]
AmTrust Securities Litigation
November 16, 2022. The Court in the Amtrust securities matter (Southern District of New York) approved a class action settlement in the amount of $13 million. Plaintiff alleged that defendants misrepresented and omitted material facts concerning the future of the company’s preferred shares, including the shares’ continued listing on the NYSE. Professor Steven Feinstein of […]
